Findings on HIV/AIDS Reported by Investigators at Chiang Mai University (Efficacy, Safety, and Tolerability of Doravirine/lamivudine/tenofovir Disoproxil Fumarate Fixed-dose Combination Tablets In Adolescents Living With Hiv: Results Through...).

A study conducted at Chiang Mai University in Thailand examined the efficacy, safety, and tolerability of a fixed-dose combination of doravirine, lamivudine, and tenofovir disoproxil fumarate (DOR FDC) in adolescents living with HIV-1. The study included 45 participants aged 12 to 17 years, and the results showed that DOR FDC was effective in maintaining viral suppression through 96 weeks. The treatment was well-tolerated, with no serious adverse events or treatment discontinuations. This research provides valuable insights into the use of DOR FDC in adolescents with HIV-1. [Extracted from the article]

Copyright of AIDS Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)